Craft

Proteomics International

Stock Price

$0.6

2024-10-04

Market Capitalization

$91 M

2024-10-04

Revenue

$960 K

FY, 2025

Proteomics International Summary

Company Summary

Overview
Proteomics International is a contract research company focused on proteomics and providing predictive diagnostic and bioanalytical services. The company develops and commercializes diagnostic tests for chronic diseases. Its main product is PromarkerD, a predictive test for the diagnosis of diabetic kidney disease (DKD).
Type
Public
Status
Active
Founded
2001
HQ
Nedlands, AU | view all locations
Website
https://www.proteomics.com.au/
Cybersecurity rating
Sectors

Key People

  • Richard Lipscombe

    Richard Lipscombe, Managing Director

    LocationsView all

    2 locations detected

    • Nedlands, WA HQ

      Australia

      6 Verdun St

    • Nedlands, WA

      Australia

      Broadway

    Proteomics International Financials

    Summary Financials

    Revenue (H1, 2026)
    $357.0K
    Gross profit (H1, 2026)
    $730.0K
    Net income (H1, 2026)
    ($6.1M)
    Cash (H1, 2026)
    $7.7M
    EBIT (H1, 2026)
    ($6.2M)

    Footer menu